These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 15893725)

  • 1. Structural basis for an unexpected mode of SERM-mediated ER antagonism.
    Wu YL; Yang X; Ren Z; McDonnell DP; Norris JD; Willson TM; Greene GL
    Mol Cell; 2005 May; 18(4):413-24. PubMed ID: 15893725
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Selective estrogen receptor modulators with conformationally restricted side chains. Synthesis and structure-activity relationship of ERalpha-selective tetrahydroisoquinoline ligands.
    Renaud J; Bischoff SF; Buhl T; Floersheim P; Fournier B; Geiser M; Halleux C; Kallen J; Keller H; Ramage P
    J Med Chem; 2005 Jan; 48(2):364-79. PubMed ID: 15658851
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular mechanism of action at estrogen receptor alpha of a new clinically relevant antiestrogen (GW7604) related to tamoxifen.
    Bentrem D; Dardes R; Liu H; MacGregor-Schafer J; Zapf J; Jordan V
    Endocrinology; 2001 Feb; 142(2):838-46. PubMed ID: 11159857
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quantitative comparison of the inhibitory effects of GW5638 and tamoxifen on angiogenesis in the cornea pocket assay.
    Tong S; Chen Q; Shan SQ; Dewhirst MW; Yuan F
    Angiogenesis; 2006; 9(2):53-8. PubMed ID: 16622786
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of molecular and structural determinants of selective estrogen receptor downregulators.
    Fan M; Rickert EL; Chen L; Aftab SA; Nephew KP; Weatherman RV
    Breast Cancer Res Treat; 2007 May; 103(1):37-44. PubMed ID: 17033922
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structural characterization of a subtype-selective ligand reveals a novel mode of estrogen receptor antagonism.
    Shiau AK; Barstad D; Radek JT; Meyers MJ; Nettles KW; Katzenellenbogen BS; Katzenellenbogen JA; Agard DA; Greene GL
    Nat Struct Biol; 2002 May; 9(5):359-64. PubMed ID: 11953755
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Conformational dynamics of the estrogen receptor alpha: molecular dynamics simulations of the influence of binding site structure on protein dynamics.
    Celik L; Lund JD; Schiøtt B
    Biochemistry; 2007 Feb; 46(7):1743-58. PubMed ID: 17249692
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Definition of functionally important mechanistic differences among selective estrogen receptor down-regulators.
    Wittmann BM; Sherk A; McDonnell DP
    Cancer Res; 2007 Oct; 67(19):9549-60. PubMed ID: 17909066
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Potential of endogenous estrogen receptor beta to influence the selective ER modulator ERbeta complex.
    Chen B; Gajdos C; Dardes R; Kidwai N; Johnston SR; Dowsett M; Jordan VC
    Int J Oncol; 2005 Aug; 27(2):327-35. PubMed ID: 16010412
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Small-angle X-ray scattering studies on structures of an estrogen-related receptor alpha ligand binding domain and its complexes with ligands and coactivators.
    Jin KS; Park JK; Yoon J; Rho Y; Kim JH; Kim EE; Ree M
    J Phys Chem B; 2008 Aug; 112(32):9603-12. PubMed ID: 18646811
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tamoxifen and raloxifene differ in their functional interactions with aspartate 351 of estrogen receptor alpha.
    Dayan G; Lupien M; Auger A; Anghel SI; Rocha W; Croisetière S; Katzenellenbogen JA; Mader S
    Mol Pharmacol; 2006 Aug; 70(2):579-88. PubMed ID: 16679488
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Estrogen receptor α L543A,L544A mutation changes antagonists to agonists, correlating with the ligand binding domain dimerization associated with DNA binding activity.
    Arao Y; Hamilton KJ; Coons LA; Korach KS
    J Biol Chem; 2013 Jul; 288(29):21105-21116. PubMed ID: 23733188
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential SERM activation of the estrogen receptors (ERalpha and ERbeta) at AP-1 sites.
    Weatherman RV; Clegg NJ; Scanlan TS
    Chem Biol; 2001 May; 8(5):427-36. PubMed ID: 11358690
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Implications of the binding of tamoxifen to the coactivator recognition site of the estrogen receptor.
    Kojetin DJ; Burris TP; Jensen EV; Khan SA
    Endocr Relat Cancer; 2008 Dec; 15(4):851-70. PubMed ID: 18755852
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Selective estrogen-receptor modulators and antihormonal resistance in breast cancer.
    Jordan VC; O'Malley BW
    J Clin Oncol; 2007 Dec; 25(36):5815-24. PubMed ID: 17893378
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impaired helix 12 dynamics due to proline 892 substitutions in the androgen receptor are associated with complete androgen insensitivity.
    Elhaji YA; Stoica I; Dennis S; Purisima EO; Lumbroso R; Beitel LK; Trifiro MA
    Hum Mol Genet; 2006 Mar; 15(6):921-31. PubMed ID: 16449235
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Potential use of an estrogen-glucocorticoid receptor chimera as a drug screen for tissue selective estrogenic activity.
    Maru BS; Tobias JH; Rivers C; Caunt CJ; Norman MR; McArdle CA
    Bone; 2009 Jan; 44(1):102-12. PubMed ID: 18976723
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Structural insights into Resveratrol's antagonist and partial agonist actions on estrogen receptor alpha.
    Chakraborty S; Levenson AS; Biswas PK
    BMC Struct Biol; 2013 Oct; 13():27. PubMed ID: 24160181
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of aspartate 351 in transactivation and active conformation of estrogen receptor alpha.
    Kim JH; Lee MH; Kim BJ; Kim JH; Han SJ; Kim HY; Stallcup MR
    J Mol Endocrinol; 2005 Dec; 35(3):449-64. PubMed ID: 16326832
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Estrogen receptors as therapeutic targets in breast cancer.
    Ariazi EA; Ariazi JL; Cordera F; Jordan VC
    Curr Top Med Chem; 2006; 6(3):181-202. PubMed ID: 16515478
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.